A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
UroGen Pharma Ltd.
Radiation Therapy Oncology Group
UroGen Pharma Ltd.
UroGen Pharma Ltd.
Corewell Health West
Mayo Clinic
Viralytics
Halozyme Therapeutics
Memorial Sloan Kettering Cancer Center